Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department

Clinical trial NCT06315920 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06315920
Sponsor: Oman Medical Speciality Board
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle-Cell Disease with Crisis

Start date: 2026-05-01
Primary completion: 2028-05-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.